This article describes various experimental models of seizure and epilepsy. Epilepsy is characterised by recurrent unprovoked seizures. Antiepileptic drug discovery in animal models starts with the assumption that the experimental seizure model mimics human seizure. Hence a drug which suppresses ictogenesis or inhibits epileptogenesis in animal model is a potential antiepileptic drug for human and it needs further investigation. Phenytoin and Carbamazepine were identified with the help of relatively simple models like Maximal electroshock seizure and the pentylenetetrazole test. Lots of drugs were discovered with the help of these models but a big portion of patients still remains resistant to the available antiepileptic drugs. Again these ...
Despite the development of numerous novel antiepileptic drugs (AEDs) in recent years, several unmet ...
According to the World Health Organization, the prevalence of epilepsy in the world is high, at abou...
Current antiseizure therapy is ineffective in approximately one third of people with epilepsy and is...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
AbstractAnimal models for seizures and epilepsy have played a fundamental role in advancing our unde...
The development of effective antiepileptic drugs (AEDs) is crucial in the management of epile...
Introduction: Epilepsy is one of the neurological pathologies with the highest rate of incidence and...
Introduction: Absence epilepsy is a brief non-convulsive seizure associated with sudden abruptness i...
The objective of this programme of work was to study experimental seizure models and new antiepilept...
Epilepsy is one of the most common chronic disorders affecting individuals of all ages. A greater un...
Epilepsy is a common neurological disorder characterized by seizures which result in distinctive neu...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
AbstractBackground: There is a need to discover novel chemical compounds that will inhibit the patho...
Introduction: New antiepileptic drugs are needed because many epileptic patients do not achieve comp...
This article describes current experimental models of status epilepticus (SE) and neuronal injury fo...
Despite the development of numerous novel antiepileptic drugs (AEDs) in recent years, several unmet ...
According to the World Health Organization, the prevalence of epilepsy in the world is high, at abou...
Current antiseizure therapy is ineffective in approximately one third of people with epilepsy and is...
Nowadays, there are various animal models of acute and chronic seizures. Some chemical and electrica...
AbstractAnimal models for seizures and epilepsy have played a fundamental role in advancing our unde...
The development of effective antiepileptic drugs (AEDs) is crucial in the management of epile...
Introduction: Epilepsy is one of the neurological pathologies with the highest rate of incidence and...
Introduction: Absence epilepsy is a brief non-convulsive seizure associated with sudden abruptness i...
The objective of this programme of work was to study experimental seizure models and new antiepilept...
Epilepsy is one of the most common chronic disorders affecting individuals of all ages. A greater un...
Epilepsy is a common neurological disorder characterized by seizures which result in distinctive neu...
OBJECTIVE: Epilepsy affects ~50 million people worldwide causing significant medical, financial, and...
AbstractBackground: There is a need to discover novel chemical compounds that will inhibit the patho...
Introduction: New antiepileptic drugs are needed because many epileptic patients do not achieve comp...
This article describes current experimental models of status epilepticus (SE) and neuronal injury fo...
Despite the development of numerous novel antiepileptic drugs (AEDs) in recent years, several unmet ...
According to the World Health Organization, the prevalence of epilepsy in the world is high, at abou...
Current antiseizure therapy is ineffective in approximately one third of people with epilepsy and is...